8-K: VSee Health, Inc. Completes Business Combination, Begins Trading on Nasdaq

Digital Health Acquisition Corp. has completed its merger with VSee Lab, Inc. and iDoc Virtual Telehealth Solutions, Inc., and will now operate as VSee Health, Inc., trading on Nasdaq under the ticker symbol VSEE.

Summary

• Digital Health Acquisition Corp. (DHAC) has finalized its business combination with VSee Lab, Inc. and iDoc Virtual Telehealth Solutions, Inc.
• The combined entity is now named VSee Health, Inc. and will trade on Nasdaq under the ticker symbol VSEE starting June 25, 2024.
• VSee Health will be led by co-CEOs Milton Chen and Imoigele Aisiku, and CFO Jerry Leonard.
• The business combination involved the merger of DHAC with VSee Lab and iDoc, with VSee Lab and iDoc becoming wholly-owned subsidiaries of VSee Health.
• DHAC's common stock and warrants were re-designated as VSee Health's common stock and warrants, respectively.
• VSee Lab stockholders received approximately 0.40 shares of VSee Health common stock for each share of VSee Lab Class A common stock.
• iDoc stockholders received approximately 994.38 shares of VSee Health common stock for each share of iDoc Class A common stock.
• Certain indebtedness of DHAC, VSee Lab, and iDoc was converted into 1,788 shares of Series A Preferred Stock of VSee Health.
• 892,500 shares of VSee Health common stock were issued to certain lenders after the closing.
• 4,370 shares of Series A Preferred Stock were issued to A.G.P./Alliance Global Partners upon closing.
• The total number of outstanding shares of VSee Health common stock immediately following the closing was approximately 14,692,820.
• A senior convertible promissory note with an aggregate principal value of $2,523,744.29 was issued to a bridge investor.
• A 7% original issue discount convertible promissory note in the aggregate principal amount of $3,000,000 was issued to an institutional investor.

Sentiment

Score: 7

Explanation: The document is generally positive, highlighting the completion of a significant transaction and the potential for future growth. However, it also acknowledges risks and uncertainties, which tempers the overall sentiment.

Positives

• The business combination creates a company with a comprehensive suite of telehealth solutions.
• VSee Health is positioned to capitalize on the growing digital health market.
• The company has a strong leadership team with experience in telemedicine and healthcare technology.
• The company has secured significant funding through convertible notes.

Negatives

• The company has a significant amount of debt from the convertible notes.
• The company has a complex capital structure with multiple classes of stock and warrants.
• The company is subject to various risks and uncertainties, including competition and regulatory changes.

Risks

• The company faces competition from larger technology companies with greater resources.
• The company's success depends on its ability to maintain and grow its customer base.
• The company's financial performance is subject to market conditions and global economic factors.
• The company's ability to raise financing in the future is uncertain.
• The company's success depends on the commercialization and adoption of its products and services.
• The company's ability to obtain and maintain regulatory approval for its products is uncertain.

Future Outlook

The company contains forward-looking statements regarding future financial and operating results, plans, strategies, and objectives, but cautions that actual results may differ materially due to various factors.

Management Comments

• We believe that VSee Health is poised to leverage the combined strengths of VSee Lab and iDoc Virtual Telehealth Solutions in the rapidly growing digital health market, aiming to drive innovation and deliver cutting-edge solutions that enhance patient outcomes and streamline the delivery of telemedicine, said Milton Chen, co-CEO of VSee Health.
• We believe that VSee Health is positioned to potentially capture a significant share of this market, leveraging our comprehensive suite of solutions and strong industry relationships to help unify a complex landscape of technologies into a single interface for healthcare providers of all sizes, added Imo Aisiku, co-CEO of VSee Health.

Industry Context

The announcement reflects the ongoing trend of consolidation in the digital health market, as companies seek to expand their offerings and market reach. The combination of VSee Lab's software platform and iDoc's telehealth services positions VSee Health to compete in the rapidly growing telemedicine sector.

Comparison to Industry Standards

• The document does not provide specific financial results to compare against industry standards.
• However, the document does mention that the global digital health market is experiencing rapid growth, suggesting that VSee Health is operating in a sector with high potential.
• The document also highlights the company's focus on providing a comprehensive suite of solutions and strong industry relationships, which are important factors for success in the competitive telehealth market.
• The document does not provide specific details on the company's technology or services that would allow for a comparison to industry benchmarks.

Management Changes

Corporate Governance

Legal Proceedings

• The document references legal proceedings in the Proxy Statement/Prospectus/Consent Solicitation, but does not provide specific details.

Related Party Transactions

• The document mentions that certain indebtedness of DHAC, VSee Lab, and iDoc was converted into Series A Preferred Stock, and that 892,500 shares of VSee Health common stock were issued to certain lenders after the closing, and 4,370 shares of Series A Preferred Stock were issued to A.G.P./Alliance Global Partners upon closing. These transactions may involve related parties.

Stakeholder Impact

• Shareholders of DHAC, VSee Lab, and iDoc will now hold shares in VSee Health, Inc.
• Employees of VSee Lab and iDoc will become employees of VSee Health, Inc.
• Customers of VSee Lab and iDoc will now be customers of VSee Health, Inc.
• Creditors of DHAC, VSee Lab, and iDoc may be affected by the terms of the business combination.

Next Steps

• VSee Health common stock and warrants will begin trading on Nasdaq on June 25, 2024.
• The company will focus on integrating the operations of VSee Lab and iDoc.
• The company will continue to develop and commercialize its telehealth solutions.

Key Dates

Keywords

telehealth, digital health, merger, acquisition, business combination, healthcare, software, SaaS, virtual care, neurocritical care, intensive care, promissory note, convertible note, Nasdaq